1. A review of drug-related acute pancreatitis

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Anaphylaxis and skin testing

   Newsletter Article 05 February 2013 Pages: 2 - 3

3. Iatrogenic manic disorders

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. Atracurium besilate: postmarketing surveillance in the USA …

   Newsletter Article 05 February 2013 Pages: 3 - 3

5. … and in the United Kingdom

   Newsletter Article 05 February 2013 Pages: 4 - 4

6. Ambroxol

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Antidepressants overdose

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Antipsychotics

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Aspirin

   Newsletter Article 05 February 2013 Pages: 4 - 4

10. Atenolol/methyldopa

    Newsletter Article 05 February 2013 Pages: 4 - 4

11. Benzoyl peroxide

    Newsletter Article 05 February 2013 Pages: 5 - 5

12. Buspirone interaction

    Newsletter Article 05 February 2013 Pages: 5 - 5

13. Calcium carbonate

    Newsletter Article 05 February 2013 Pages: 5 - 5

14. Carbamazepine overdose

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Cefroxadine

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Clonidine

    Newsletter Article 05 February 2013 Pages: 5 - 5

17. Danazol

    Newsletter Article 05 February 2013 Pages: 5 - 5

18. Diazepam

    Newsletter Article 05 February 2013 Pages: 5 - 6

19. Erythromycin overdose

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Fluoxetine see Buspirone interaction

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Glycopyrronium bromide +; neostigmine

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Halothane

    Newsletter Article 05 February 2013 Pages: 6 - 6

23. Halothane/isoflurane

    Newsletter Article 05 February 2013 Pages: 6 - 6

24. Hydroquinone

    Newsletter Article 05 February 2013 Pages: 6 - 6

25. Hypoglycaemics

    Newsletter Article 05 February 2013 Pages: 6 - 6

26. Ibuprofen

    Newsletter Article 05 February 2013 Pages: 6 - 6

27. Ifosfamide

    Newsletter Article 05 February 2013 Pages: 6 - 7

28. Interferon alpha 2A see Paracetamol interaction

    Newsletter Article 05 February 2013 Pages: 7 - 7

29. Isoflurane see Halothane/isoflurane

    Newsletter Article 05 February 2013 Pages: 7 - 7

30. Isoniazid

    Newsletter Article 05 February 2013 Pages: 7 - 7

31. Isoniazid/rifampicin

    Newsletter Article 05 February 2013 Pages: 7 - 7

32. Lithium

    Newsletter Article 05 February 2013 Pages: 7 - 8

33. Lovastatin

    Newsletter Article 05 February 2013 Pages: 8 - 8

34. Mepacrine

    Newsletter Article 05 February 2013 Pages: 8 - 8

35. Methoxsalen

    Newsletter Article 05 February 2013 Pages: 8 - 8

36. Methyldopa see Atenolol/methyldopa

    Newsletter Article 05 February 2013 Pages: 8 - 8

37. Midazolam

    Newsletter Article 05 February 2013 Pages: 8 - 8

38. Minocycline

    Newsletter Article 05 February 2013 Pages: 8 - 9

39. Neostigmine see Glycopyrronium bromide +; neostigmine

    Newsletter Article 05 February 2013 Pages: 9 - 9

40. Paracetamol interaction

    Newsletter Article 05 February 2013 Pages: 9 - 9

41. Paraquat poisoning

    Newsletter Article 05 February 2013 Pages: 9 - 9

42. Pentostatin

    Newsletter Article 05 February 2013 Pages: 9 - 9

43. Phenazopyridine

    Newsletter Article 05 February 2013 Pages: 9 - 9

44. Phytomenadione

    Newsletter Article 05 February 2013 Pages: 9 - 9

45. Potassium bromide

    Newsletter Article 05 February 2013 Pages: 9 - 9

46. Prednisolone

    Newsletter Article 05 February 2013 Pages: 10 - 10

47. Psoralens +; ultraviolet A light

    Newsletter Article 05 February 2013 Pages: 10 - 10

48. Ranitidine see Theophylline interaction

    Newsletter Article 05 February 2013 Pages: 10 - 10

49. Retinol

    Newsletter Article 05 February 2013 Pages: 10 - 10

50. Rifampicin see Isoniazid/rifampicin

    Newsletter Article 05 February 2013 Pages: 10 - 10